SciFluor Life Sciences Closes $5M First Round
SciFluor Life Sciences has raised $5 million from Allied Minds. The first round of funding is designed to support commercialization of its technology to enable late-stage fluorination of pharmaceutical drug candidates and other commercial chemicals. The company’s technology is based on technology developed by Harvard professor Tobias Ritter and his colleagues in the school’s department of chemistry and chemical biology. Allied Minds is a private equity-funded company with offices in Boston and Los Angeles.
17 May 2011•4 mins read
